Form D · Pharmaceuticals
Antivirus Therapeutics, Inc.
Princeton Jct., NJ · CIK 0001588163
Offering snapshot reported Oct 1, 2013 · SEC filing
- Reported sold
- $743K Offering amount: $5M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 5, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 1, 2013 | Initial | $742,500 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-203821
Source: Form D, filed Oct 1, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Anand Gumaste | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
7 Ardsley Ct.
Princeton Jct., NJ, 08550
Princeton Jct., NJ, 08550